Spark Investment Management’s Myriad Genetics MYGN Stock Holding History

Spark Investment Management’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-55,600	Closed	-$1.62M	–	689
2018 Q4	$1.62M	Sell	55,600 -33,100	-37%	-$1.19M	0.11%	235
2018 Q3	$4.08M	Buy	88,700 +23,800	+37%	+$1.06M	0.23%	140
2018 Q2	$2.42M	Buy	+64,900	New	+$2.19M	0.14%	207
2017 Q4	–	Sell	-178,100	Closed	-$6.44M	–	766
2017 Q3	$6.44M	Sell	178,100 -77,600	-30%	-$2.21M	0.35%	88
2017 Q2	$6.61M	Sell	255,700 -40,400	-14%	-$858K	0.41%	59
2017 Q1	$5.68M	Hold	296,100	–	–	0.36%	63
2016 Q4	$4.93M	Buy	296,100 +41,300	+16%	+$747K	0.41%	52
2016 Q3	$5.24M	Buy	+254,800	New	+$6.46M	0.42%	54
2014 Q4	–	Sell	-12,100	Closed	-$466K	–	769
2014 Q3	$466K	Buy	+12,100	New	+$451K	0.07%	367

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Spark Investment Management's MYGN Position: Q1 2019 in Review

Spark Investment Management sold out of Myriad Genetics (MYGN) in Q1 2019, closing a stake of 55,600 shares — an estimated $1.62M sold.

Spark Investment Management first reported a position in MYGN in Q3 2014 and held it in 9 quarters. The position peaked at $6.61M in Q2 2017. 262 funds tracked by Wall St. Rank hold MYGN as of Q1 2019.

Spark Investment Management reported no remaining Myriad Genetics position as of Q1 2019 after selling out during the quarter.
Spark Investment Management sold 55,600 Myriad Genetics shares in Q1 2019, an estimated $1.62M.
Spark Investment Management first reported a position in Myriad Genetics in Q3 2014 and held it in 9 quarters.
Spark Investment Management's Myriad Genetics position peaked at $6.61M in Q2 2017.
262 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2019.

Based on Spark Investment Management's 13F filing for Q1 2019, filed 7 May 2019.